Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Multifaced Generation of MOF Coatings via Vapor-Phase Sublimation and Deposition Reactions

Hu SM., Lee CY., Chang YM., Chou FY., Wang HH., Chiang YC.

Laboratory Study on Face & Skin, published in ACS Appl Mater Interfaces (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
ACS Appl Mater Interfaces (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41392398
PMCID
PMC12828722
DOI
10.1021/acsami.5c16493

Abstract (original English)

A general fabrication method for metal-organic framework (MOF) coatings through a vapor sublimation and deposition process is reported. The vapor-phase fabrication mechanism relies on the interplay between thermodynamic properties and the solid-vapor interface reaction. The processing parameters of ion concentration, vapor pressure, and system temperature enable control of the sublimation rate, and ion-linker nucleation and coordination reactions occur at the dynamic solid-vapor interface to form the proposed MOF coatings. The reaction rate is controllable and is proportional to the sublimation rate during the fabrication process. On the basis of the proposed fabrication mechanism, experiments are facilitated to obtain combinations of multiple metal cores and a variety of functionalized linkers for vapor deposition from solid solution sublimation. The fabrication process involves pore size control, crystalline orientation customization, and encapsulation of cargo to form composite coatings, and these processes are implemented during the same one coating fabrication process. The initiation and manipulation of the nucleation radius and thus the nucleation rate are easy to control and are related to the fabricated MOF coatings with tunable crystalline morphologies. Moreover, the MOF coating thickness is a time-dependent process that is proportional to the sublimation rate and depo

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research